FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Major Pharmaceuticals Unit Dose Valsartan Tablets Recall

Unit Dose Valsartan Tablets, USP, 80 mg

MAJOR PHARMACEUTICALS · Livonia, MI

Risk level
Class II
Reported by FDA
Aug 1, 2018
Recall ID
D-0966-2018
Check your lot numberHow we source this data

Summary

Major Pharmaceuticals recalled Unit Dose Valsartan Tablets starting Jul 18, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0966-2018 on Aug 1, 2018. Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Status: Terminated.

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Product description

Unit Dose Valsartan Tablets, USP, 80 mg. Rx only, Distributed by: Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61.

Lot numbers, UPCs & expiration codes

Major Label Unit Dose 10 x 10 Cartons 80 mg Item # 302086. Lot# T-01270 (Expiry: 7/18). Lot# T-01466 (Expiry: 7/18). Lot# T-01500 (Expiry:2/19). Lot# T-01596 (Expiry: 2/19). Lot# T-01625 (Expiry: 2/19). Lot# T-01712 (Expiry: 2/19). Lot# T-01795 (5/19). Lot# T-01807 (Expiry: 5/19).

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0966-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 18, 2018
FDA report date
Aug 1, 2018
Quantity
5,464 cartons
Recall type
N/A
Recalling firm
MAJOR PHARMACEUTICALS

Original FDA data

Every field from FDA enforcement report D-0966-2018, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
80557
Address
17177 N Laurel Park Dr
Code information
Major Label Unit Dose 10 x 10 Cartons 80 mg Item # 302086. Lot# T-01270 (Expiry: 7/18). Lot# T-01466 (Expiry: 7/18). Lot# T-01500 (Expiry:2/19). Lot# T-01596 (Expiry: 2/19). Lot# T-01625 (Expiry: 2/19). Lot# T-01712 (Expiry: 2/19). Lot# T-01795 (5/19). Lot# T-01807 (Expiry: 5/19).
Postal code
48152-2693
Report date
Aug 1, 2018
Product type
Drugs
Recall number
D-0966-2018
Classification
Class II
Recalling firm
MAJOR PHARMACEUTICALS
Product quantity
5,464 cartons
Termination date
Oct 2, 2022
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Product description
Unit Dose Valsartan Tablets, USP, 80 mg. Rx only, Distributed by: Major Pharmaceuticals, Livonia, MI 48152, NDC# 0904-6594-61.
Distribution pattern
Nationwide.
Recall initiation date
Jul 18, 2018
Center classification date
Jul 20, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0966-2018, published Aug 1, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls